Trial Library Secures $10 Million Series A to Democratize Clinical Trial Access Through AI-Enabled Community Platform
核心洞察
Trial Library (搜索) raised $10 million in Series A funding co-led by SemperVirens Venture Capital (搜索) and Next Ventures (搜索) to expand its AI-enabled platform that connects community healthcare providers with clinical trials.
The platform currently operates across 320+ clinics and 1,500+ providers nationwide, addressing the gap where 85% of cancer (搜索) patients receive treatment in community settings but trials are concentrated in academic centers.
The company has demonstrated significant impact with 642 patient referrals in one year through The Oncology Institute partnership and focuses on diversity with 69% of referrals being non-white patients.
Trial Library (搜索), an AI-enabled platform expanding access to clinical trials in community healthcare settings, announced the completion of a $10 million Series A funding round co-led by SemperVirens Venture Capital (搜索) and Next Ventures (搜索). The round included participation from Sanofi Ventures (搜索), Lux Capital (搜索), Civilization Ventures, How Women Invest, Overwater Ventures and other investors, bringing the company's total funding to $15 million.
The San Francisco-based company addresses a critical gap in clinical trial access, where approximately 85% of cancer (搜索) patients receive treatment in community settings while clinical trials have historically been concentrated in large research institutions.
Platform Demonstrates Measurable Impact
Trial Library (搜索)'s AI-enabled platform operates across more than 320 clinics and works with over 1,500 healthcare providers nationwide. The platform unlocks access to clinical trials through AI-enabled provider activation, compliant eligible patient identification and longitudinal navigation throughout the trial lifecycle.
The company has demonstrated significant impact through strategic partnerships with leading healthcare organizations. Trial Library (搜索)'s collaboration with The Oncology Institute generated 642 patient referrals in one year, while partnerships with American Oncology Network (搜索) identified tens of eligible patients for solid tumor (搜索) trials in just the first quarter of implementation.
"As a physician-scientist, I witnessed, first-hand, the significant impact clinical trials have on improved healthcare outcomes. At Trial Library (搜索), we're building the connective tissue that links care delivery and clinical research," said Dr. Hala Borno, CEO and founder of Trial Library. "This latest funding will enable us to advance our model where access to innovation is the standard, not the exception."
Addressing Diversity and Access Barriers
Trial Library (搜索) has prioritized diversity and equity among patient populations, with 69% of patient referrals being non-white, 29% on Medicaid and 44% requiring transportation support. This focus addresses critical gaps in clinical trial participation while reducing administrative burden on providers and transforming how community oncology practices engage with clinical research.
"Trial Library (搜索) is the first technology company to unlock the payer market to effectively broaden the pool of patients who are considered for clinical trials," said Allison Baum Gates, general partner of SemperVirens Venture Capital (搜索). "We're excited to back a platform that aligns incentives and unites patients, providers, payers, and life-science partners around shared cost-savings and patient outcomes."
Strategic Biopharmaceutical Partnerships
The platform has established partnerships with leading global biopharmaceutical companies to accelerate R&D and enrollment. Trial Library (搜索) expanded its collaboration with Johnson & Johnson Innovative Medicine to support oncology clinical development and medical affairs programs, and in 2025 announced a collaboration with Texas Oncology (搜索) to streamline clinical trial access through personalized patient navigation.
"Trial Library (搜索) is a uniquely end-to-end platform, building the AI infrastructure that is accelerating access to the next generation of precision medicine," said Cris De Luca, partner at Sanofi Ventures (搜索).
Expanding Payer Partnerships
Trial Library (搜索) is rapidly expanding its network alongside growing partnerships with payers such as self-insured plans and health plans, positioning clinical trials as a care benefit option for patients.
"Trial Library (搜索)'s approach aligns with the growing shift toward decentralized, community-based research," said Lance Armstrong, managing partner at Next Ventures (搜索). "They're proving that AI and human navigation together can bring precision medicine to every corner of healthcare."
The company plans to use the new funding to grow its clinic network, strengthen partnerships, and continue building the infrastructure required to make clinical trial access a standard option for patients across the United States.